Drug Development

Alzheimer's Disease (AD) is a debilitating neurodegenerative disorder affecting an estimated 55 million people world-wide. With no clear understanding of disease mechanism, hypothesis-based AD drug discovery has proven to be a high-risk endeavor. The TREAT-AD Consortium was initiated to improve...

Full description

Saved in:
Bibliographic Details
Published in:Alzheimer's & dementia 2025-12, Vol.21 Suppl 5, p.e103791
Main Authors: Leal, Karina, Zoeller, Elizabeth L, Cary, Gregory A, Wiley, Jesse C, Du, Yuhong, Halabelian, Levon, Axtman, Alison D, Betarbet, Ranjita, Carter, Gregory W, Fu, Haian, Longo, Frank, Rizzo, Stacey J Sukoff, Edwards, Aled M, Levey, Allan I
Format: Article
Language:English
Subjects:
Alzheimer Disease - drug therapy
Drug Development - methods
Drug Discovery - methods
Humans
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!